Neurogene (NGNE) PT Raised to $55 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts NGNE Hot Sheet
Price: $38.63 +1.68%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
H.C. Wainwright analyst Mitchel Kapoor raised the price target on Neurogene (NASDAQ: NGNE) to $55.00 (from $45.00) while maintaining a Buy rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- Kuaishou Technology (1024:HK) PT Lowered to HK$27.60 at Macquarie
- Netease Inc. (9999:HK) (NTES) PT Lowered to HK$226 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
